Intest Res.  2019 Jul;17(3):365-374. 10.5217/ir.2018.00173.

Real-time data monitoring for ulcerative colitis: patient perception and qualitative analysis

• Walsh A
• Matini L
• Hinds C
• Sexton V
• Brain O
• Keshav S
• Geddes J
• Goodwin G
• Collins G
• Travis S
• Peters M

• KMID: 2454745
• DOI: http://doi.org/10.5217/ir.2018.00173

Abstract

BACKGROUND/AIMS
TrueColours ulcerative colitis (TCUC) is a comprehensive web-based program that functions through email, providing direct links to questionnaires. Several similar programs are available, however patient perspectives are unexplored.
METHODS
A pilot study was conducted to determine feasibility, usability and patient perceptions of real-time data collection (daily symptoms, fortnightly quality of life, 3 monthly outcomes). TCUC was adapted from a web-based program for patients with relapsing-remitting bipolar disorder, using validated UC indices. A semi-structured interview was developed and audio-recorded face-to-face interviews were conducted after 6 months of interaction with TCUC. Transcripts were coded in NVivo11, a qualitative data analysis software package. An inductive approach and thematic analysis was conducted.
RESULTS
TCUC was piloted in 66 patients for 6 months. Qualitative analysis currently defies statistical appraisal beyond "data saturation," even if it has more influence on clinical practice than quantitative data. A total of 28 face-to-face interviews were conducted. Six core themes emerged: awareness, control, decision-making, reassurance, communication and burden of treatment. There was a transcending overarching theme of patient empowerment, which cut across all aspects of the TCUC experience.
CONCLUSIONS
Patient perception of the impact of real-time data collection was extremely positive. Patients felt empowered as a product of the self-monitoring format of TCUC, which may be a way of improving self-management of UC whilst also decreasing the burden on the individual and healthcare services.

Keyword

Electronic data processing; Colitis, ulcerative; Perception

MeSH Terms

Automatic Data Processing
Bipolar Disorder
Colitis, Ulcerative*
Data Collection
Delivery of Health Care
Electronic Mail
Humans
Patient Participation
Pilot Projects
Quality of Life
Self Care
Statistics as Topic
Ulcer*

Figure

• 

  Fig. 1. Examples of TrueColours ulcerative colitis functionality. (A) Screenshot of email prompt with link to symptom and quality of life (QoL) questionnaires. (B) Screenshot of symptom questionnaire with response options. (C) Screenshot of patient dashboard displaying patient’s medication timeline, SCCAI (symptoms) and IBD control (QoL) graphs. SCCAI, Simple Clinical Colitis Activity Index.

• 

  Fig. 2. Semi-structured guide for face-to-face interviews for patients using TrueColours ulcerative colitis for 6 months.

Reference

1. Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011; 140:1785–1794.

2. Moradkhani A, Beckman LJ, Tabibian JH. Health-related quality of life in inflammatory bowel disease: psychosocial, clinical, socioeconomic, and demographic predictors. J Crohns Colitis. 2013; 7:467–473.

3. Irvine EJ. Quality of life of patients with ulcerative colitis: past, present, and future. Inflamm Bowel Dis. 2008; 14:554–565.

4. Ghosh S, Mitchell R. Impact of inflammatory bowel disease on quality of life: results of the European Federation of Crohn’s and Ulcerative Colitis Associations (EFCCA) patient survey. J Crohns Colitis. 2007; 1:10–20.

5. Chiauzzi E, Rodarte C, DasMahapatra P. Patient-centered activity monitoring in the self-management of chronic health conditions. BMC Med. 2015; 13:77.

6. Franklin V, Waller A, Pagliari C, Greene S. “Sweet Talk”: text messaging support for intensive insulin therapy for young people with diabetes. Diabetes Technol Ther. 2003; 5:991–996.

7. Friedman RH, Kazis LE, Jette A, et al. A telecommunications system for monitoring and counseling patients with hypertension. Impact on medication adherence and blood pressure control. Am J Hypertens. 1996; 9:285–292.

8. Pinnock H, Slack R, Pagliari C, Price D, Sheikh A. Professional and patient attitudes to using mobile phone technology to monitor asthma: questionnaire survey. Prim Care Respir J. 2006; 15:237–245.

9. Rasmussen LM, Phanareth K, Nolte H, Backer V. Internet-based monitoring of asthma: a long-term, randomized clinical study of 300 asthmatic subjects. J Allergy Clin Immunol. 2005; 115:1137–1142.

10. Barlow J, Wright C, Sheasby J, Turner A, Hainsworth J. Selfmanagement approaches for people with chronic conditions: a review. Patient Educ Couns. 2002; 48:177–187.

11. Dinesen B, Andersen PE. Qualitative evaluation of a diabetes advisory system, DiasNet. J Telemed Telecare. 2006; 12:71–74.

12. Dinesen B, Nøhr C, Andersen SK, Sejersen H, Toft E. Under surveillance, yet looked after: telehomecare as viewed by patients and their spouse/partners. Eur J Cardiovasc Nurs. 2008; 7:239–246.

13. Atreja A, Khan S, Rogers JD, et al. Impact of the mobile HealthPROMISE platform on the quality of care and quality of life in patients with inflammatory bowel disease: study protocol of a pragmatic randomized controlled trial. JMIR Res Protoc. 2015; 4:e23.

14. de Jong M, van der Meulen-de Jong A, Romberg-Camps M, et al. Development and feasibility study of a telemedicine tool for all patients with IBD: MyIBDcoach. Inflamm Bowel Dis. 2017; 23:485–493.

15. Elkjaer M, Shuhaibar M, Burisch J, et al. E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided ‘Constant-care’ approach. Gut. 2010; 59:1652–1661.

16. Cross RK, Arora M, Finkelstein J. Acceptance of telemanagement is high in patients with inflammatory bowel disease. J Clin Gastroenterol. 2006; 40:200–208.

17. Castro HK, Cross RK, Finkelstein J. Using a Home Automated Telemanagement (HAT) system: experiences and perceptions of patients with inflammatory bowel disease. AMIA Annu Symp Proc. 2006; 2006:872.

18. Kim AH, Roberts C, Feagan BG, et al. Developing a standard set of patient-centred outcomes for inflammatory bowel disease-an international, cross-disciplinary consensus. J Crohns Colitis. 2018; 12:408–418.

19. Peters M, Abu-Saad HH, Vydelingum V, Murphy M. Research into headache: the contribution of qualitative methods. Headache. 2002; 42:1051–1059.

20. Pope C, Mays N. Reaching the parts other methods cannot reach: an introduction to qualitative methods in health and health services research. BMJ. 1995; 311:42–45.

21. Magro F, Gionchetti P, Eliakim R, et al. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. J Crohns Colitis. 2017; 11:649–670.

22. Walmsley RS, Ayres RC, Pounder RE, Allan RN. A Simple Clinical Colitis Activity Index. Gut. 1998; 43:29–32.

23. Bodger K, Ormerod C, Shackcloth D, Harrison M; IBD Control Collaborative. Development and validation of a rapid, generic measure of disease control from the patient’s perspective: the IBD-control questionnaire. Gut. 2014; 63:1092–1102.

24. Alrubaiy L, Cheung WY, Dodds P, et al. Development of a short questionnaire to assess the quality of life in Crohn’s disease and ulcerative colitis. J Crohns Colitis. 2015; 9:66–76.

25. Williams JG, Alam MF, Alrubaiy L, et al. Comparison Of iNfliximab and ciclosporin in STeroid Resistant Ulcerative Colitis: pragmatic randomised Trial and economic evaluation (CONSTRUCT). Health Technol Assess. 2016; 20:1–320.

26. EuroQol Group. EuroQol: a new facility for the measurement of health-related quality of life. Health Policy. 1990; 16:199–208.

27. NVivo qualitative data analysis software, version 11. QSR International Pty Ltd;QSR International Pty Ltd: 2015.

28. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006; 3:77–101.

29. Tong A, Sainsbury P, Craig J. Consolidated Criteria for Reporting Qualitative Research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007; 19:349–357.

30. Velikova G, Booth L, Smith AB, et al. Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial. J Clin Oncol. 2004; 22:714–724.

31. Detmar SB, Muller MJ, Schornagel JH, Wever LD, Aaronson NK. Health-related quality-of-life assessments and patientphysician communication: a randomized controlled trial. JAMA. 2002; 288:3027–3034.

32. Haywood K, Marshall S, Fitzpatrick R. Patient participation in the consultation process: a structured review of intervention strategies. Patient Educ Couns. 2006; 63:12–23.

33. Gerrity P. And to think that it happened on 11th street: a nursing approach to community-based holistic care and health care reform. Altern Ther Health Med. 2010; 16:62–67.

34. Takeuchi EE, Keding A, Awad N, et al. Impact of patient-reported outcomes in oncology: a longitudinal analysis of patient-physician communication. J Clin Oncol. 2011; 29:2910–2917.

35. Harley C, Takeuchi E, Taylor S, et al. A mixed methods approach to adapting health-related quality of life measures for use in routine oncology clinical practice. Qual Life Res. 2012; 21:389–403.

36. Chantler T, Paton C, Velardo C, et al. Creating connections – the development of a mobile-health monitoring system for heart failure: qualitative findings from a usability cohort study. Digit Health. 2016; 2:2055207616671461.

37. Ha JF, Longnecker N. Doctor-patient communication: a review. Ochsner J. 2010; 10:38–43.

38. Santana MJ, Feeny D, Johnson JA, et al. Assessing the use of health-related quality of life measures in the routine clinical care of lung-transplant patients. Qual Life Res. 2010; 19:371–379.

39. Seto E, Leonard KJ, Cafazzo JA, Barnsley J, Masino C, Ross HJ. Perceptions and experiences of heart failure patients and clinicians on the use of mobile phone-based telemonitoring. J Med Internet Res. 2012; 14:e25.

40. Santana MJ, Feeny D. Framework to assess the effects of using patient-reported outcome measures in chronic care management. Qual Life Res. 2014; 23:1505–1513.

41. Seto E, Leonard KJ, Cafazzo JA, Barnsley J, Masino C, Ross HJ. Mobile phone-based telemonitoring for heart failure management: a randomized controlled trial. J Med Internet Res. 2012; 14:e31.

42. Eton DT, Yost KJ, Lai JS, et al. Development and validation of the Patient Experience with Treatment and Self-management (PETS): a patient-reported measure of treatment burden. Qual Life Res. 2017; 26:489–503.

43. Hernandez-Tejada MA, Campbell JA, Walker RJ, Smalls BL, Davis KS, Egede LE. Diabetes empowerment, medication adherence and self-care behaviors in adults with type 2 diabetes. Diabetes Technol Ther. 2012; 14:630–634.

44. Cerezo PG, Juvé-Udina ME, Delgado-Hito P. Concepts and measures of patient empowerment: a comprehensive review. Rev Esc Enferm USP. 2016; 50:667–674.

45. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006; 55:749–753.